Scarica l'app Stockscreener
24.78
0.94%
0.23
Dopo l'orario di chiusura:
25.21
0.43
+1.74%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché FMS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$24.55
Aprire:
$24.91
Volume 24 ore:
293.18K
Relative Volume:
1.09
Capitalizzazione di mercato:
$14.41B
Reddito:
$20.87B
Utile/perdita netta:
$715.14M
Rapporto P/E:
20.30
EPS:
1.2209
Flusso di cassa netto:
$1.67B
1 W Prestazione:
+2.14%
1M Prestazione:
+2.35%
6M Prestazione:
+16.28%
1 anno Prestazione:
+28.53%
Intervallo 1D:
$24.75
$25.11
Intervallo di 1 settimana:
$24.13
$25.11
Portata 52W:
$17.93
$25.25
Fresenius Medical Care Ag Adr Stock (FMS) Company Profile
Nome
Fresenius Medical Care Ag Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta FMS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FMS
Fresenius Medical Care Ag Adr
|
24.78 | 14.41B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
HCA
Hca Healthcare Inc
|
342.16 | 84.29B | 70.60B | 5.76B | 5.64B | 21.97 |
|
DVA
Davita Inc
|
150.22 | 13.37B | 12.67B | 827.68M | 1.42B | 9.27 |
|
THC
Tenet Healthcare Corp
|
133.14 | 13.01B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
186.18 | 11.80B | 15.42B | 1.03B | 956.84M | 15.02 |
Fresenius Medical Care Ag Adr Stock (FMS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-02 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-11-06 | Iniziato | Berenberg | Buy |
| 2024-01-08 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-11-24 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2023-11-17 | Aggiornamento | Societe Generale | Hold → Buy |
| 2023-08-14 | Downgrade | UBS | Buy → Neutral |
| 2023-08-01 | Ripresa | Citigroup | Neutral |
| 2023-07-12 | Iniziato | Goldman | Buy |
| 2023-03-07 | Iniziato | Bernstein | Mkt Perform |
| 2023-01-03 | Downgrade | Jefferies | Buy → Underperform |
| 2022-10-26 | Downgrade | Deutsche Bank | Hold → Sell |
| 2022-10-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-10-10 | Downgrade | Jefferies | Buy → Hold |
| 2022-06-27 | Aggiornamento | Jefferies | Underperform → Buy |
| 2022-02-11 | Downgrade | Jefferies | Hold → Underperform |
| 2021-11-23 | Iniziato | HSBC Securities | Hold |
| 2021-11-11 | Aggiornamento | Jefferies | Underperform → Hold |
| 2021-02-04 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-02-03 | Downgrade | Deutsche Bank | Buy → Hold |
| 2020-08-05 | Downgrade | Jefferies | Buy → Hold |
| 2020-05-20 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-21 | Aggiornamento | Jefferies | Hold → Buy |
| 2019-06-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-12-10 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-26 | Aggiornamento | UBS | Neutral → Buy |
| 2018-08-28 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2018-07-05 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2018-01-04 | Aggiornamento | UBS | Sell → Neutral |
| 2017-12-11 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-01 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2016-09-06 | Aggiornamento | Citigroup | Neutral → Buy |
| 2016-07-08 | Aggiornamento | Jefferies | Underperform → Hold |
| 2016-01-04 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2015-11-04 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2015-09-03 | Aggiornamento | Goldman | Neutral → Buy |
| 2015-08-13 | Downgrade | Societe Generale | Buy → Hold |
| 2015-07-31 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2013-08-02 | Reiterato | Feltl & Co. | Hold |
| 2013-01-14 | Aggiornamento | HSBC Securities | Neutral → Overweight |
Mostra tutto
Fresenius Medical Care Ag Adr Borsa (FMS) Ultime notizie
Dry Bicarbonate Concentrate Bags for Hemodialysis in the State of São Paulo in Brazil - Fresenius Medical Care
Fresenius Economic Profit Margins Should Rise Along With Improvement in Both Operating Segments - Morningstar
Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum - Fresenius Medical Care
Kidney Disease: Evolving the Standard of Care - Fresenius Medical Care
Sanctuary Advisors LLC Acquires New Holdings in Fresenius Medical Care AG (NYSE:FMS) - MarketBeat
Fresenius Medical Care ADR earnings missed by $0.26, revenue fell short of estimates - Investing.com South Africa
Fresenius Medical Care published form 20-F for the fiscal year 2024 - Fresenius Medical Care
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Earnings call transcript: Fresenius Medical Care sees strong Q4 2024 growth - Investing.com
Fresenius Medical Care Q4 earnings miss estimates, stock edges higher - Investing.com
Dialysis firm FMC beats profit estimates in fourth quarter By Reuters - Investing.com
Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025 - Fresenius Medical Care
Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics - Fresenius Medical Care
Growing Stronger Together: Embracing Diversity - Fresenius Medical Care
Corporate Citizenship - Fresenius Medical Care
Fresenius Medical Care: A 'Buy' Going Into 2025 (NYSE:FMS) - Seeking Alpha
Virtual reality as the next step in patient empowerment - Fresenius Medical Care
Coming Back Home: Dr. Len Usvyat Appointed as the Next Head of the Renal Research Institute - Fresenius Medical Care
17,962 miles halfway around the world - Fresenius Medical Care
“How can we improve and speed up medical decisions?” - Fresenius Medical Care
20 years creating a future worth living - Fresenius Medical Care
When Maria struck — One year after the hurricane - Fresenius Medical Care
Our Way Forward - Fresenius Medical Care
Corporate Movie 2021 - Fresenius Medical Care
Our way forward - Fresenius Medical Care
The Next Level of Renal Care - Fresenius Medical Care
Me and my four kidneys - Fresenius Medical Care
A superhero wins over Asia-Pacific - Fresenius Medical Care
Joining forces for a better future - Fresenius Medical Care
Improving dialysis through knowledge sharing in Southeast Asia - Fresenius Medical Care
A truly miraculous story – 50 years on dialysis - Fresenius Medical Care
Smart Companion for an active lifestyle - Fresenius Medical Care
The future is purple - Fresenius Medical Care
Regenerative Medicine: The road to healing - Fresenius Medical Care
The Life Long Learner - Fresenius Medical Care
Africa changing times - Fresenius Medical Care
A journey of friendship: How home hemodialysis changed Annalese's life - Fresenius Medical Care
20 years Fresenius Medical Care - Fresenius Medical Care
Making transplants safer and more widely available - Fresenius Medical Care
Remuneration of the Supervisory Board - Fresenius Medical Care
Compensation of the Management Board - Fresenius Medical Care
The Impact of Antihypertensive Medications on Intradialytic Hypotension - Fresenius Medical Care
High-Volume HDF, reduced mortality & patient-reported outcomes - Fresenius Medical Care
A Bold Vision to Accelerate Adoption of Value-Based Kidney Care - Fresenius Medical Care
“How can we offer our patients the best possible treatment?” - Fresenius Medical Care
Wearable Artificial Organs Global Market Research 2023-2024 & Forecasts to 2034: Government Funding and Initiatives, & Patient Preference for Non-Invasive Solutions Boost Growth - GlobeNewswire Inc.
A Savior Overlooked - Fresenius Medical Care
Global development in the new Technology Center in Schweinfurt. - Fresenius Medical Care
Learning to move - Fresenius Medical Care
Stronger together throughout the pandemic – for our patients - Fresenius Medical Care
Diary of a dialysis patient - Fresenius Medical Care
Fresenius Medical Care Ag Adr Azioni (FMS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):